Center of Rehabilitation, UMCG Groningen, the Netherlands, introduces the OPRA™ Implant System and Targeted Muscle Reinnervation (TMR).

Located approximately 200 kilometers from the nation’s capital, The University Medical Center Groningen (UMCG) is one of the largest hospitals in the Netherlands, and is the largest employer in the Northern Netherlands.

UMCG focuses on advanced care, education, training, and research; and not only provides patient-centric care, but also aims to conduct revolutionary scientific and educational research on treating the healthy aged population. This in order to build the future of healthcare, and a healthy and active population.

Committed to these values, the UMCG is one of the pioneering medical centers which has introduced the OPRA™ Implant System in the treatment of both upper and lower extremity amputees. The Center of Rehabilitation being able to offer osseointegration treatment combined with TMR, provides a “state of the art” treatment option for amputees in the Netherlands.

The efficient and highly skilled team is led by Professor and Department Chair of Orthopedics, Dr. P. C. Jutte, and is comprised of plastic surgeon Dr. T.R. Middelberg, Dr. A. H. Vrieling, department of Rehabilitation Medicine, Professor Dr. J.H.B. Geertzen, specializing in lower extremity amputation, and Professor Dr. C.K. van der Sluis, who specializes in upper extremity rehabilitation.

Says Professor Jutte, “we’re driven to enhance the ability of our amputee patients to the max so they’re able to fully participate in society; the introduction of OPRA™ and TMR will benefit them tremendously”.

Maria Lopez, CEO at Integrum, shared the following “we are both extremely pleased and proud of the collaboration with UMCG Groningen, a leading medical center which offers evidence based, cutting edge treatment to all of its patients”.

For further information, please contact:
Maria Lopez, CEO
Cell. +46 (0) 708-46 10 69

Certified Adviser:
Erik Penser Bank AB
Tel. +46 (0) 8 463 8000